SureTrader
Interactive Brokers Advertisement
Home > Boards > US Listed > Medical - Drugs > Valeant Pharmaceuticals International (VRX)

IMHO, a 15% drop is way too much.

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
JLS Member Profile
 
Followed By 46
Posts 6,129
Boards Moderated 0
Alias Born 12/14/04
160x600 placeholder
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 11/21/2017 6:27:17 PM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 11/21/2017 4:25:32 PM
Valeant Announces Closing Of Add-On Secured Notes And Credit Agreement Amendment "PR Newswire (Canada)" - 11/21/2017 4:15:00 PM
Valeant Announces Closing Of Add-On Secured Notes And Credit Agreement Amendment "PR Newswire (US)" - 11/21/2017 4:15:00 PM
Valeant To Participate At The Evercore ISI Biopharma Catalyst/Deep Dive Conference "PR Newswire (Canada)" - 11/21/2017 8:00:00 AM
Valeant To Participate At The Evercore ISI Biopharma Catalyst/Deep Dive Conference "PR Newswire (US)" - 11/21/2017 8:00:00 AM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 11/20/2017 6:02:10 PM
TroyGould Advises Haitong International in its $190 Million Acquisition of Obagi Skincare Products Business "PR Newswire (US)" - 11/16/2017 1:00:00 PM
Bausch + Lomb Helps To Recycle More Than One Million Units Of Contact Lens Materials Within First Year Of Launching The ONE B... "PR Newswire (Canada)" - 11/15/2017 8:00:00 AM
Bausch + Lomb Helps To Recycle More Than One Million Units Of Contact Lens Materials Within First Year Of Launching The ONE B... "PR Newswire (US)" - 11/15/2017 8:00:00 AM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 11/14/2017 5:02:27 PM
Valeant Announces Pricing Of Private Offering Of Add-On Secured Notes "PR Newswire (Canada)" - 11/14/2017 4:10:00 PM
Valeant Announces Pricing Of Private Offering Of Add-On Secured Notes "PR Newswire (US)" - 11/14/2017 4:10:00 PM
Ortho Dermatologics Announces Aspire Higher Scholarship Honorees "PR Newswire (Canada)" - 11/14/2017 9:00:00 AM
Ortho Dermatologics Announces Aspire Higher Scholarship Honorees "PR Newswire (US)" - 11/14/2017 9:00:00 AM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 11/13/2017 7:47:10 AM
Valeant Announces Launch of Private Offering of Add-On Secured Notes "PR Newswire (Canada)" - 11/13/2017 7:35:00 AM
Valeant Announces Launch of Private Offering of Add-On Secured Notes "PR Newswire (US)" - 11/13/2017 7:35:00 AM
Valeant Pharmaceuticals Completes Sale of Obagi Medical Products Business to Haitong International Zhongua Finance Acquisitio... "PR Newswire (Canada)" - 11/10/2017 7:00:00 AM
Valeant Pharmaceuticals Completes Sale of Obagi Medical Products Business to Haitong International Zhongua Finance Acquisitio... "PR Newswire (US)" - 11/10/2017 7:00:00 AM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 11/9/2017 7:54:54 AM
Valeant To Participate At The Stifel 2017 Healthcare Conference "PR Newswire (Canada)" - 11/8/2017 6:02:00 PM
Valeant To Participate At The Stifel 2017 Healthcare Conference "PR Newswire (US)" - 11/8/2017 6:02:00 PM
EyeGate Completes Enrollment in Phase 2b Clinical Trial of EGP-437 for Cataract Surgery "GlobeNewswire Inc." - 11/8/2017 8:30:00 AM
Quarterly Report (10-q) "Edgar (US Regulatory)" - 11/7/2017 5:29:18 PM
JLS   Thursday, 11/09/17 04:26:01 PM
Re: JohnCM post# 3869
Post # of 3982 
IMHO, a 15% drop is way too much.

The catastrophe that would cause VRX to go back 15% is a bear market.

Given that a bear market is not on the horizon; IMO a 15% drop in VRX is not where you should stop out of your position. That is where you should double down on your position.

At this point I think it is reasonable for VRX to trade around the $16.50 to $17.50 area as it did last July.


Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist